Newsletter

Charlie Youlden

Charlie is an Associate Equity Research Analyst covering ASX small caps across technology, mining and industrials.

His investing journey began in 2020 with large-cap US technology stocks, before he went on to complete a Commerce degree in Finance and Marketing at UTS, the Wall Street Prep Financial Modelling course, and Columbia Business School’s Value Investing course.

Charlie’s goal is to make investing clear, digestible and genuinely useful for everyday retail investors, helping them make better decisions with more confidence.

984 articles published

Mining Stocks Uncategorized Uranium Stocks

ASX Uranium Stocks: Best 3 Picks for the Long-Term

Not all commodities are created equal. Gold has long been the world’s safe haven, lithium has become the lifeblood of our electric future and uranium, well, uranium might just be the next step for shaping the next era of energy. We still remember the first time we looked at a uranium price chart and realised…

ByCharlie YouldenAugust 14, 20250Comments

Defence Stocks Growth Stocks Small Caps Stocks Technology Uncategorized

Orbital (ASX: OEC) up 15%: investors bet on defence tailwinds

The Future of Flight Isn't About the Drone: It’s About the Engine This morning, Orbital Corporation (ASX: OEC) soared 15%, riding a wave of investor excitement following the appointment of Stephen Pearce as CEO and a strong quarterly report. The future of warfare, surveillance, and logistics will not be decided by who builds the biggest…

ByCharlie YouldenAugust 12, 20250Comments

News Tech Stocks Technology Uncategorized

Tuas Just Made a $1.43B Acquisition of M1: Opportunity or Overreach?

Tuas (ASX:TUA) Bets Big on M1: A Game-Changing Move in Singapore’s Telco Market What if the next big telco growth story is not about building more towers, but about buying the keys to an already successful network? Tuas Limited has just made its boldest move yet, agreeing to acquire M1 Limited’s non-ICT operations for S$1.43…

ByCharlie YouldenAugust 12, 20250Comments

Biotech Stocks

4DMedical 100% Surge: Beginning of a Breakout or the Peak?

4DMedical Doubles in a Month: Momentum or Peak? A 100 percent share price surge in just one month will always turn heads, but the real question is whether the story has just begun or is already peaking. That’s the situation facing investors watching 4DMedical (ASX:4DX), a small-cap respiratory imaging company now riding the momentum of…

ByCharlie YouldenAugust 12, 20250Comments

Blue Chip Stocks Tech Stocks Technology

Why TPG’s $651M Bid for Infomedia Could Backfire; And Why the ASX was Embarrassed by the Deal

What does it say about a company when one of the world’s biggest private equity firms offers a 30 percent premium to take it off the public market? That’s the question investors are asking after TPG announced a $651 million all-cash deal to acquire Infomedia Ltd (ASX:IFM), a quiet achiever in the automotive software space. If…

ByCharlie YouldenAugust 8, 20250Comments

Uncategorized

Shopify Stock Jumps 100% From April: Can The Run Continue?

What if the real winner of the AI and e-commerce boom isn’t a retailer, but the platform quietly powering their growth from behind the scenes? On August 6th, Shopify surprised Wall Street. The stock jumped 21 percent in a single day, fueled by a strong Q2 earnings report, surging GMV, accelerating revenue, and a solid 16…

ByCharlie YouldenAugust 8, 20250Comments

Uncategorized

What if the future of global clean energy hinges on a remote hillside in Malawi?

As governments race to secure rare earths, the essential ingredients in electric vehicles, wind turbines, and military tech, investors are turning their eyes to new supply chains beyond China. That’s where Lindian Resources (ASX: LIN) enters the picture. The company just signed a 15-year offtake agreement and secured a US$20 million construction loan from Iluka…

ByCharlie YouldenAugust 8, 20250Comments

AI Stocks Uncategorized

How Trump’s 100% Chip Tariff Could Shake Up Tech Supply Chain

In the 1800s, gold was power. In 2025, it’s semiconductors. On Wednesday, August 6th, Donald Trump announced a sweeping 100 percent tariff on imported chips, unless they’re made in America or from companies actively reshoring production. It’s not just a headline grab. It’s the latest move in a high-stakes global chess game where control over chip…

ByCharlie YouldenAugust 8, 20250Comments

Biotech Stocks Healthcare Stocks Large Caps

Telix SEC Subpoena Explained: Why the Stock Plunged 31%

What Investors Need to Know About the Telix SEC Subpoena What happens when a fast-growing biotech lands a major U.S. listing, then suddenly finds itself in the SEC’s crosshairs? That’s the question Telix Pharmaceuticals (ASX:TLX) investors are now asking after the company disclosed it had received a subpoena from the U.S. Securities and Exchange Commission.…

ByCharlie YouldenAugust 8, 20250Comments

Blue Chip Stocks Semiconductor stocks

Onsemi Stock Crashes 16%: Short-Term Panic or Long-Term Trouble?

Is this the moment onsemi loses its spark or sets up its biggest comeback yet? On August 5th, onsemi’s stock (NASDAQ:ON) nosedived 16% in a single day, capping off a brutal year that has already seen the company shed over 22% of its value. It was the worst-performing stock in the S&P 500 that Monday,…

ByCharlie YouldenAugust 5, 20250Comments